ABUS

#2561
Arbutus Biopharma Corporation Common Stock
4.35 USD
-0.46%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
4.35
4.35
Faixa anual
2.94
5.10
Mudança diária
-0.46%
Mudança mensal
+1.16%
Mudança em 6 meses
+2.59%
Mudança anual
+32.62%
Fechamento anterior
4.37
Abrir
4.35
Bid
Ask
Mínimo
4.35
High
4.35
Volume
83
Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
  • Market Capitalization 850.33 M
  • Employee 19
  • Founded 2007
  • CEO William H. Collier
  • Website www.arbutusbio.com
  • Headquarter British Columbia, Canada
  • FIGI BBG000RR8V85
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-28.29
Price to sales ratio
65.44

Arbutus Biopharma Corporation

Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007.

Notícias